Mahadevan, Nikhil http://orcid.org/0000-0003-0257-9311
Christakis, Yiorgos http://orcid.org/0000-0003-3371-8935
Di, Junrui http://orcid.org/0000-0001-6325-8090
Bruno, Jonathan
Zhang, Yao
Dorsey, E. Ray
Pigeon, Wilfred R.
Beck, Lisa A. http://orcid.org/0000-0002-8452-667X
Thomas, Kevin
Liu, Yaqi
Wicker, Madisen http://orcid.org/0000-0002-6240-0208
Brooks, Chris http://orcid.org/0000-0002-9511-5390
Kabiri, Nina Shaafi http://orcid.org/0000-0001-8951-2237
Bhangu, Jaspreet
Northcott, Carrie
Patel, Shyamal
Funding for this research was provided by:
Pfizer
Article History
Received: 11 September 2020
Accepted: 15 January 2021
First Online: 3 March 2021
Competing interests
: N.M., Y.C., J.D., J.B., Y.Z., C.N., and S.P. are current employees of Pfizer, Inc. E.R.D., K.T., Y.L., M.W., C.B., N.S.K., and J.B. have no competing interests. W.R.P. has been a consultant to Curaegis Technologies, Inc. L.A.B. has been a principal investigator for Pfizer atopic dermatitis trials as well as a consultant.